Cost-effectiveness of current and optimal treatment for schizophrenia
- 1 November 2003
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 183 (5) , 427-435
- https://doi.org/10.1192/bjp.183.5.427
Abstract
Background: This paper is part of a project to identify the proportion of the burden of each mental disorder averted by current and optimal interventions, and the cost-effectiveness of both.Aims: To use epidemiological data on schizophrenia to model the cost-effectiveness of current and optimal treatment.Method: Calculate the burden of schizophrenia in the years lived with disability (YLD) component of disability-adjusted life-years lost, the proportion averted by current interventions, the proportion that could be averted by optimal treatment and the cost-effectiveness of both.Results: Current interventions avert some 13% of the burden, whereas 22% could be averted by optimal treatment. Current interventions cost about AUS$200 000 per YLD averted, whereas optimal treatment at a similar cost could increase the number of YLDs averted by two-thirds. Even so, the majority of the burden of schizophrenia remains unavertable.Conclusions: Optimal treatment is affordable within the present budget and should be implemented.Keywords
This publication has 32 references indexed in Scilit:
- When Is It Cost-effective to Change the Behavior of Health Professionals?JAMA, 2001
- Mental Disorders and Burden of Disease: How was Disability Estimated and is It Valid?Australian & New Zealand Journal of Psychiatry, 2001
- The Prevention of Schizophrenia: What Interventions Are Safe and Effective?Schizophrenia Bulletin, 2001
- Psychotic Disorders in Urban Areas: An Overview of the Study on Low Prevalence DisordersAustralian & New Zealand Journal of Psychiatry, 2000
- Community mental health teams: evidence or belief?The British Journal of Psychiatry, 1999
- Early Detection and Intervention With Schizophrenia: RationaleSchizophrenia Bulletin, 1996
- How much better is clozapine? A meta-analytic review and critical appraisal.Experimental and Clinical Psychopharmacology, 1995
- Congruence of Service Utilization Estimates From the Epidemiologic Catchment Area Project and Other SourcesArchives of General Psychiatry, 1993
- The Economic Costs of SchizophreniaArchives of General Psychiatry, 1985
- Treatment Outlines for the Management of SchizophreniaAustralian & New Zealand Journal of Psychiatry, 1984